MARKET

MXCT

MXCT

Maxcyte
NASDAQ
1.130
-0.170
-13.08%
Pre Market: 1.160 +0.03 +2.65% 05:38 11/11 EST
OPEN
1.400
PREV CLOSE
1.300
HIGH
1.420
LOW
1.080
VOLUME
1.15K
TURNOVER
0
52 WEEK HIGH
1.805
52 WEEK LOW
0.6434
MARKET CAP
116.62M
P/E (TTM)
-3.3842
1D
5D
1M
3M
1Y
5Y
1D
MaxCyte (MXCT) Q3 2026 Earnings Call Transcript
The Motley Fool · 5h ago
MaxCyte Q3 2026 Earnings Call Transcript
Benzinga · 13h ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 13h ago
MaxCyte falls after $151.8M deal to buy Akron Bio for cash and stock
Seeking Alpha · 16h ago
MaxCyte to acquire Akron BioProducts for $151.8M
TipRanks · 17h ago
MaxCyte reports Q3 EPS (5c), consensus (8c)
TipRanks · 17h ago
MaxCyte Reports Strong Third-Quarter Revenue Growth and Narrower Loss
TipRanks · 20h ago
MaxCyte FY2026 Revenue expected to be more than $34.500M vs $32.211M Est
Benzinga · 21h ago
More
About MXCT
MaxCyte, Inc. is a cell-engineering focused company providing solutions to advance the discovery, development and commercialization of cell therapeutics. It leverages its cell engineering technology platform to enable the programs of its biotechnology and pharmaceutical company customers who are engaged in cell therapy. Its ExPERT platform, which is based on its Flow Electroporation technology, is designed to support the expanding cell therapy market and can be utilized across the continuum of the cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes four instruments, the ATx, STx, GTx and VLx; a portfolio of proprietary related processing assemblies or disposables; and software protocols, all supported by a worldwide intellectual property portfolio. It also provides comprehensive off-target risk assessment solutions for gene editing, through ONE-seq and GUIDE-seq platforms.

Webull offers MaxCyte Inc stock information, including NASDAQ: MXCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MXCT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MXCT stock methods without spending real money on the virtual paper trading platform.